S&P 500   4,023.89
DOW   32,196.66
QQQ   301.94
S&P 500   4,023.89
DOW   32,196.66
QQQ   301.94
S&P 500   4,023.89
DOW   32,196.66
QQQ   301.94
S&P 500   4,023.89
DOW   32,196.66
QQQ   301.94
LON:SNG

Synairgen (SNG) Share Forecast, Price & News

GBX 26.70
+3.36 (+14.40%)
(As of 05/13/2022 09:00 PM ET)
Add
Compare
Today's Range
23.02
26.70
50-Day Range
20.52
27.50
52-Week Range
10
223.80
Volume
1.90 million shs
Average Volume
4.27 million shs
Market Capitalization
£53.76 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A
30 days | 90 days | 365 days | Advanced Chart
Receive SNG News and Ratings via Email

Sign-up to receive the latest news and ratings for Synairgen and its competitors with MarketBeat's FREE daily newsletter.

Synairgen logo

About Synairgen

Synairgen plc discovers and develops drugs for respiratory diseases. It develops SNG001, inhaled interferon beta for the treatment of COVID-19; inhaled interferon beta (IFN-ß), which is in Phase-II clinical trials for the treatment of asthma caused by the common cold and flu; IFN-ß that is in Phase-II clinical trials for the treatment or prevention of chronic obstructive pulmonary disease exacerbations caused by the common cold and flu; and LOXL2 inhibitor, which has completed Phase II clinical trial for the treatment of idiopathic pulmonary fibrosis (IPF) and non-alcoholic fatty liver diseases. The company has a licensing and collaboration agreement with Pharmaxis Ltd. to develop a LOXL2 inhibitor. Synairgen plc was incorporated in 2004 and is headquartered in Southampton, the United Kingdom.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
18
Year Founded
N/A

Sales & Book Value

Annual Sales
£79 thousand
Cash Flow
GBX 23.10 per share
Book Value
GBX 26.20 per share

Profitability

Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Market Cap
£53.76 million
Optionable
Not Optionable

Company Calendar

Last Earnings
9/29/2020
Today
5/15/2022
Next Earnings (Estimated)
5/25/2022

MarketRank

Overall MarketRank

0.75 out of 5 stars

Analyst Opinion: 0.0Community Rank: 3.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -













Synairgen (LON:SNG) Frequently Asked Questions

When is Synairgen's next earnings date?

Synairgen is scheduled to release its next quarterly earnings announcement on Wednesday, May 25th 2022.
View our earnings forecast for Synairgen
.

How were Synairgen's earnings last quarter?

Synairgen plc (LON:SNG) issued its earnings results on Tuesday, September, 29th. The company reported ($3.11) EPS for the quarter.
View Synairgen's earnings history
.

Who are Synairgen's key executives?
Synairgen's management team includes the following people:
  • Mr. Richard Marsden, CEO, MD & Exec. Director (Age 54, Pay $415k)
  • Prof. Stephen T. Holgate CBE, M.D., Co-Founder, Non-Exec. Director & Member of Scientific Advisory Board (Age 74, Pay $25k)
  • Mr. John Ward, CFO & Exec. Director (Age 60, Pay $324k)
  • Dr. Phillip David Monk, Chairman of Scientific Advisory Board, Chief Scientific Officer & Exec. Director (Age 53, Pay $302k)
  • Prof. Donna Davies, Co-Founder & Member of Scientific Advisory Board
  • Prof. Ratko Djukanovic, Co-Founder & Member of Scientific Advisory Board
  • Ms. Brooke Clarke, Head of Communications
  • Dr. Gareth E. Walters Ph.D., Chief Regulatory Officer (Age 63)
  • Ms. Jody Brookes, Head of Clinical Operations
  • Mr. Richard Hennings, Chief Commercial Officer (Age 52)
What other stocks do shareholders of Synairgen own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Synairgen investors own include Alibaba Group (BABA), Yamana Gold (YRI), Eldorado Gold (ELD), Ocado Group (OCDO), Polo Resources (POL), Silvercorp Metals (SVM), W Resources (WRES), Associated British Foods (ABF), Ariana Resources (AAU) and First Majestic Silver (AG).

What is Synairgen's stock symbol?

Synairgen trades on the London Stock Exchange (LON) under the ticker symbol "SNG."

How do I buy shares of Synairgen?

Shares of SNG and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Synairgen's stock price today?

One share of SNG stock can currently be purchased for approximately GBX 26.70.

How much money does Synairgen make?

Synairgen has a market capitalization of £53.76 million and generates £79 thousand in revenue each year.

How many employees does Synairgen have?

Synairgen employs 18 workers across the globe.

What is Synairgen's official website?

The official website for Synairgen is www.synairgen.com.

How can I contact Synairgen?

Synairgen's mailing address is Southampton General Hosp, Tremona Road, SOUTHAMPTON, SO16 6YD, United Kingdom. The company can be reached via phone at +44-23-80512800.

This page was last updated on 5/16/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.